XML 68 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Guarantor Financial Information (Details 4) (USD $)
In Thousands, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities:    
Net cash provided by (used in) continuing operations $ 52,853 $ 19,224
Net cash provided by discontinued operations 1,039 3,518
Net cash provided by operating activities 53,892 22,742
Cash flows from investing activities:    
Capital expenditures (99,214) (106,990)
Proceeds from sale of property, plant and equipment 10,863 14,945
Escrow deposit for MidCon acquisition (17,000)  
Return of investments in non-consolidated affiliates 4,890 4,665
Cash invested in non-consolidated subsidiaries (197)  
Net cash used in continuing operations (100,658) (87,380)
Net cash provided by discontinued operations 16,726 30,674
Net cash used in investing activities (83,932) (56,706)
Cash flows from financing activities:    
Proceeds from borrowings of long-term debt 332,500 1,204,037
Repayments of long-term debt (255,500) (1,145,251)
Payments for debt issuance costs   (11,373)
Payments for settlement of interest rate swaps that include financing element (913)  
Proceeds from stock options exercised 8,520 2,576
Proceeds from stock issued pursuant to our employee stock purchase plan 404 345
Purchases of treasury stock (5,349) (3,368)
Dividends to Exterran stockholders (9,989)  
Stock-based compensation excess tax benefit 6,470 1,311
Distributions to noncontrolling partners in the Partnership (15,869) (15,262)
Net cash provided by financing activities 60,274 33,015
Effect of exchange rate changes on cash and cash equivalents (4,409) (454)
Net increase (decrease) in cash and cash equivalents 25,825 (1,403)
Cash and cash equivalents at beginning of period 35,665 34,601
Cash and cash equivalents at end of period 61,490 33,198
Eliminations
    
Cash flows from investing activities:    
Capital expenditures   3,378
Proceeds from sale of property, plant and equipment   (3,378)
Capital distributions received from consolidated subsidiaries (12,971) (8,069)
Investment in consolidated subsidiaries 6,156 5,357
Return on investment in consolidated subsidiaries (7,481)  
Net cash used in continuing operations (14,296) (2,712)
Net cash used in investing activities (14,296) (2,712)
Cash flows from financing activities:    
Distributions to noncontrolling partners in the Partnership 12,971 8,069
Capital distributions to affiliates 7,481  
Capital contributions received from parent (6,156) (5,357)
Net cash provided by financing activities 14,296 2,712
Parent | Reportable Legal Entities
    
Cash flows from operating activities:    
Net cash provided by (used in) continuing operations 4,856 6,851
Net cash provided by operating activities 4,856 6,851
Cash flows from investing activities:    
Return on investment in consolidated subsidiaries 7,481  
Net cash used in continuing operations 7,481  
Net cash used in investing activities 7,481  
Cash flows from financing activities:    
Proceeds from borrowings of long-term debt 241,500 405,001
Repayments of long-term debt (208,000) (398,251)
Proceeds from stock options exercised 8,520 2,576
Proceeds from stock issued pursuant to our employee stock purchase plan 404 345
Purchases of treasury stock (5,349) (3,368)
Dividends to Exterran stockholders (9,989)  
Stock-based compensation excess tax benefit 6,470 1,311
Borrowings (repayments) between consolidated subsidiaries, net (45,862) (14,391)
Net cash provided by financing activities (12,306) (6,777)
Net increase (decrease) in cash and cash equivalents 31 74
Cash and cash equivalents at beginning of period 11 24
Cash and cash equivalents at end of period 42 98
Guarantor Subsidiaries | Reportable Legal Entities
    
Cash flows from operating activities:    
Net cash provided by (used in) continuing operations (20,344) 19,866
Net cash provided by operating activities (20,344) 19,866
Cash flows from investing activities:    
Capital expenditures (32,264) (68,670)
Proceeds from sale of property, plant and equipment 5,490 13,522
Capital distributions received from consolidated subsidiaries 12,971 8,069
Investment in consolidated subsidiaries (6,156) (5,357)
Net cash used in continuing operations (19,959) (52,436)
Net cash used in investing activities (19,959) (52,436)
Cash flows from financing activities:    
Capital distributions to affiliates (7,481)  
Borrowings (repayments) between consolidated subsidiaries, net 48,373 22,693
Net cash provided by financing activities 40,892 22,693
Net increase (decrease) in cash and cash equivalents 589 (9,877)
Cash and cash equivalents at beginning of period 1,554 10,461
Cash and cash equivalents at end of period 2,143 584
Other Subsidiaries | Reportable Legal Entities
    
Cash flows from operating activities:    
Net cash provided by (used in) continuing operations 68,341 (7,493)
Net cash provided by discontinued operations 1,039 3,518
Net cash provided by operating activities 69,380 (3,975)
Cash flows from investing activities:    
Capital expenditures (66,950) (41,698)
Proceeds from sale of property, plant and equipment 5,373 4,801
Escrow deposit for MidCon acquisition (17,000)  
Return of investments in non-consolidated affiliates 4,890 4,665
Cash invested in non-consolidated subsidiaries (197)  
Net cash used in continuing operations (73,884) (32,232)
Net cash provided by discontinued operations 16,726 30,674
Net cash used in investing activities (57,158) (1,558)
Cash flows from financing activities:    
Proceeds from borrowings of long-term debt 91,000 799,036
Repayments of long-term debt (47,500) (747,000)
Payments for debt issuance costs   (11,373)
Payments for settlement of interest rate swaps that include financing element (913)  
Distributions to noncontrolling partners in the Partnership (28,840) (23,331)
Capital contributions received from parent 6,156 5,357
Borrowings (repayments) between consolidated subsidiaries, net (2,511) (8,302)
Net cash provided by financing activities 17,392 14,387
Effect of exchange rate changes on cash and cash equivalents (4,409) (454)
Net increase (decrease) in cash and cash equivalents 25,205 8,400
Cash and cash equivalents at beginning of period 34,100 24,116
Cash and cash equivalents at end of period $ 59,305 $ 32,516